Subtypes of Parkinson's Disease: What Do They Tell Us About Disease Progression?

被引:117
|
作者
Fereshtehnejad, Seyed-Mohammad [1 ,2 ]
Postuma, Ronald B. [1 ,3 ,4 ]
机构
[1] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada
[2] Karolinska Inst, Div Clin Geriatr, Dept Neurobiol, Care Sci & Soc NVS, Stockholm, Sweden
[3] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ, Canada
[4] Montreal Gen Hosp, Dept Neurol, L7-305,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada
基金
加拿大健康研究院;
关键词
Parkinson's disease; Subtype; Progression; Motor symptoms; Nonmotor symptoms; SLEEP BEHAVIOR DISORDER; MOTOR SUBTYPE; NONMOTOR FEATURES; CLINICAL SUBTYPES; DEMENTIA; ONSET; ASSOCIATION; HETEROGENEITY; AGE; NEURODEGENERATION;
D O I
10.1007/s11910-017-0738-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease is a widely heterogeneous disorder with a broad list of motor and nonmotor manifestations. Identifying subtypes of Parkinson's disease is one of the top clinical and research priorities. This review aims to summarize the most valid conventional and recent subtyping solutions that have been introduced so far and to update our current knowledge with recent discoveries on the association between subtypes and disease progression. We also discuss the challenges of subtyping in the context of Parkinson's disease, stability of the subtypes over time, and potential clinical implications. Sophisticated evidence show that there are distinct subtypes of Parkinson's disease with diverging trends of progression. A more holistic view of subtyping to merge traditional motor features with key nonmotor manifestations is a promising approach to identify subgroups with different prognosis. Subtyping could improve further by adding continuing to add data from imaging, CSF, and genetic biomarkers.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Subtypes of Parkinson’s Disease: What Do They Tell Us About Disease Progression?
    Seyed-Mohammad Fereshtehnejad
    Ronald B. Postuma
    Current Neurology and Neuroscience Reports, 2017, 17
  • [2] What lysosomes actually tell us about Parkinson's disease?
    Bourdenx, Mathieu
    Dehay, Benjamin
    AGEING RESEARCH REVIEWS, 2016, 32 : 140 - 149
  • [3] What can biomarkers tell us about cognition in Parkinson's disease?
    Mollenhauer, Brit
    Rochester, Lynn
    Chen-Plotkin, Alice
    Brooks, David
    MOVEMENT DISORDERS, 2014, 29 (05) : 622 - 633
  • [4] What Could Posturography Tell Us About Balance Problems in Parkinson's Disease?
    Rossi-Izquierdo, Marcos
    Soto-Varela, Andres
    Ernst, Arne
    Pedro Rubio-Rodriguez, Juan
    Santos-Perez, Sofia
    Sesar, Angel
    Alberte-Woodward, Miguel
    Guijarro-Del Amo, Monica
    San Roman-Rodriguez, Elena
    Faraldo-Garcia, Ana
    Zubizarreta-Gutierrez, Alfonso
    Basta, Dietmar
    OTOLOGY & NEUROTOLOGY, 2016, 37 (09) : E326 - E331
  • [5] What a gastrointestinal biopsy can tell us about Parkinson's disease?
    Corbille, A. -G.
    Clairembault, T.
    Coron, E.
    Leclair-Visonneau, L.
    Preterre, C.
    Neunlist, M.
    Derkinderen, P.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 (07) : 966 - 974
  • [6] What substance P might tell us about the prognosis and mechanism of Parkinson's disease?
    Tirassa, Paola
    Schirinzi, Tommaso
    Raspa, Marcello
    Ralli, Massimo
    Greco, Antonio
    Polimeni, Antonella
    Possenti, Roberta
    Mercuri, Nicola Biagio
    Severini, Cinzia
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2021, 131 : 899 - 911
  • [7] Clinical Subtypes of Parkinson's Disease
    van Rooden, Stephanie M.
    Colas, Fabrice
    Martinez-Martin, Pablo
    Visser, Martine
    Verbaan, Dagmar
    Marinus, Johan
    Chaudhuri, Ray K.
    Kok, Joost N.
    van Hilten, Jacobus J.
    MOVEMENT DISORDERS, 2011, 26 (01) : 51 - 58
  • [8] Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest?
    Belvisi, Daniele
    Pellicciari, Roberta
    Fabbrini, Giovanni
    Tinazzi, Michele
    Berardelli, Alfredo
    Defazio, Giovanni
    NEUROBIOLOGY OF DISEASE, 2020, 134
  • [9] What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson's Disease?
    Xue, Jinsong
    Tao, Keju
    Wang, Weijia
    Wang, Xiaofei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [10] Do Parkinson's Disease clinical subtypes really exist?
    Filidei, Marta
    Marsili, Luca
    Colosimo, Carlo
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2025,